{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:09:46Z","timestamp":1782439786679,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostate International"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.prnil.2025.09.002","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:08:24Z","timestamp":1757776104000},"page":"22-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["External validation of the cancer of the prostate risk assessment score to predict treatment failure after high-intensity focused ultrasound"],"prefix":"10.1016","volume":"14","author":[{"suffix":"Jr.","given":"\u00c9der Silveira","family":"Braz\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Espinheira","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Camelo","family":"Mour\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Coser","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayme Quirino Caon","family":"Nobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo de P\u00e1dua","family":"Braz\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato Almeida Rosa","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1ssia","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter Henriques","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Cardoso","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00eanio de C\u00e1ssio","family":"Zequi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.prnil.2025.09.002_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/s1677-5538.ibju.2021.0091","article-title":"Available evidence on HIFU for focal treatment of prostate cancer: a systematic review","volume":"48","author":"Bakavicius","year":"2022","journal-title":"Int Braz J Urol"},{"issue":"6","key":"10.1016\/j.prnil.2025.09.002_bib2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1097\/01.ju.0000158155.33890.e7","article-title":"The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy","volume":"173","author":"Cooperberg","year":"2005","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.prnil.2025.09.002_bib3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2016.08.065","article-title":"The CAPRA score at 10 Years: contemporary perspectives and analysis of supporting studies","volume":"71","author":"Brajtbord","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2025.09.002_bib4","doi-asserted-by":"crossref","DOI":"10.1089\/end.2024.0539","article-title":"Medium-term outcomes after primary whole-gland high-intensity focused ultrasound ablation for the treatment of prostate cancer: a single-center experience","author":"Braz\u00e3o","year":"2025","journal-title":"J Endourol"},{"issue":"3","key":"10.1016\/j.prnil.2025.09.002_bib5","doi-asserted-by":"crossref","first-page":"e841","DOI":"10.1016\/S1569-9056(16)60843-6","article-title":"Medium term outcomes following focal HIFU for the treatment of non-metastatic prostate cancer: a UK registry analysis of 625 cases","volume":"15","author":"Guillaumier","year":"2016","journal-title":"Eur Urol Suppl"},{"issue":"1","key":"10.1016\/j.prnil.2025.09.002_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prnil.2023.07.004","article-title":"Prostate cancer nomograms and their application in Asian men: a review","volume":"12","author":"Panaiyadiyan","year":"2024","journal-title":"Prostate Int"},{"issue":"4","key":"10.1016\/j.prnil.2025.09.002_bib7","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.eururo.2009.12.003","article-title":"Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy","volume":"57","author":"Lughezzani","year":"2010","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.prnil.2025.09.002_bib8","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.juro.2007.07.043","article-title":"Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients","volume":"178","author":"May","year":"2007","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.prnil.2025.09.002_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.urology.2014.05.032","article-title":"Analysis of the Cancer of the Prostate Risk Assessment to predict for biochemical failure after external beam radiotherapy or prostate seed brachytherapy","volume":"84","author":"Delouya","year":"2014","journal-title":"Urology"},{"issue":"SUPPL.2","key":"10.1016\/j.prnil.2025.09.002_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1464-410X.2011.10687.x","article-title":"Comparative analysis of three risk assessment tools in Australian patients with prostate cancer","volume":"108","author":"Tamblyn","year":"2011","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.prnil.2025.09.002_bib11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.urology.2007.11.165","article-title":"External validation of university of California, San Francisco, cancer of the prostate risk assessment score","volume":"72","author":"Zhao","year":"2008","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.prnil.2025.09.002_bib12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000336924","article-title":"External validation of the cancer of the prostate risk assessment score to predict biochemical relapse after radical prostatectomy for prostate cancer in Japanese patients","volume":"89","author":"Yoshida","year":"2012","journal-title":"Urol Int"},{"issue":"11","key":"10.1016\/j.prnil.2025.09.002_bib13","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/jjco\/hyr136","article-title":"External validation of the UCSF-CAPRA (University of California, San Francisco, cancer of the prostate risk assessment) in Japanese patients receiving radical prostatectomy","volume":"41","author":"Ishizaki","year":"2011","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"10.1016\/j.prnil.2025.09.002_bib14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/bju.12587","article-title":"The Cancer of the Prostate Risk Assessment (CAPRA) score predicts biochemical recurrence in intermediate-risk prostate cancer treated with external beam radiotherapy (EBRT) dose escalation or low-dose rate (LDR) brachytherapy","volume":"114","author":"Krishnan","year":"2014","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.prnil.2025.09.002_bib15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.radonc.2011.05.080","article-title":"The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: evaluation and optimization in patients at higher risk of relapse","volume":"101","author":"Halverson","year":"2011","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.prnil.2025.09.002_bib16","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/j.1464-410X.2012.11147.x","article-title":"Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients","volume":"110","author":"Bud\u00e4us","year":"2012","journal-title":"BJU Int"},{"issue":"1014","key":"10.1016\/j.prnil.2025.09.002_bib17","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1259\/bjr\/61380797","article-title":"Prostatic cancer surveillance following whole-gland high-intensity focused ultrasound: comparison of MRI and prostate-specific antigen for detection of residual or recurrent disease","volume":"85","author":"Punwani","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.prnil.2025.09.002_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000000747","article-title":"PSA criteria to diagnose failure of cancer control following focal therapy for non-metastatic prostate cancer using high intensity focused ultrasound","author":"Huber","year":"2020","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.prnil.2025.09.002_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.urolonc.2024.12.222","article-title":"Use of biochemical and imaging criteria for selecting patients for prostate BIOPSY IN recurrence risk assessment post- HIFU therapy","volume":"43","author":"Ajami","year":"2025","journal-title":"Urol Oncol: Semin Original Investig"},{"issue":"3","key":"10.1016\/j.prnil.2025.09.002_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4111\/icu.20230435","article-title":"Applications of artificial intelligence in urologic oncology","volume":"65","author":"Pak","year":"2024","journal-title":"Investig Clin Urol"}],"container-title":["Prostate International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888225000868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888225000868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:15:37Z","timestamp":1773843337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2287888225000868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2287888225000868"],"URL":"https:\/\/doi.org\/10.1016\/j.prnil.2025.09.002","relation":{},"ISSN":["2287-8882"],"issn-type":[{"value":"2287-8882","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"External validation of the cancer of the prostate risk assessment score to predict treatment failure after high-intensity focused ultrasound","name":"articletitle","label":"Article Title"},{"value":"Prostate International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prnil.2025.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Asian Pacific Prostate Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}